Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Oxybutynin and darifenacin
(D00722)
[1] Oxybutynin[2] Oxybutynin ,
Oxybutynin chloride (D00722) 💬
[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 6 💬
2Oxybutynin hydrochloride
(D00722)
[1] Oxybutynin[2] Oxybutynin ,
Oxybutynin chloride (D00722) 💬
[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[2] 6, 13 💬
3Oxybutynin, tolterodine, solifenacin
(D00722)
[1] Oxybutynin[2] Oxybutynin ,
Oxybutynin chloride (D00722) 💬
[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 53 💬